# Chemotherapy Plus Surgery in Treating Women With Breast Cancer

> **NCT00003013** · PHASE3 · COMPLETED · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 450 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** CMF regimen
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** fluorouracil
- **DRUG:** methotrexate
- **DRUG:** paclitaxel
- **DRUG:** tamoxifen citrate
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003013
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-10
- **Primary completion:** —
- **Final completion:** 2009-03
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003013, "Chemotherapy Plus Surgery in Treating Women With Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00003013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*